These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9857461)

  • 1. [Intracardiac thrombosis and consecutive thromboembolisms in patients with heart valve diseases: predisposition and concepts for prevention].
    Piper C; Horstkotte D
    Z Kardiol; 1998; 87 Suppl 4():1-6. PubMed ID: 9857461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic therapy in native heart valve disease.
    Völler H
    J Heart Valve Dis; 2004 May; 13(3):325-8. PubMed ID: 15222275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy for patients with valvular heart disease.
    Vahanian A
    Herz; 2008 Feb; 33(1):44-51. PubMed ID: 18273577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intensity of oral anticoagulant therapy after heart valve replacement].
    Stenzinger W
    Z Kardiol; 1998; 87 Suppl 4():37-41. PubMed ID: 9857465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of thromboembolism in patients with atrial fibrillation].
    Veselka J; Bartůnĕk P
    Vnitr Lek; 1996 Nov; 42(11):792-5. PubMed ID: 9012126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What can be expected today from long-term anticoagulation for cardiac and arterial thrombosis?].
    Loeliger EA
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1483-95. PubMed ID: 3909383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation after artificial valve replacement with or without atrial fibrillation: how much is really needed?
    Verheugt FW
    Thromb Haemost; 1999 Sep; 82 Suppl 1():130-5. PubMed ID: 10695504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart failure and arrhythmia: modalities and indications of prevention of thromboembolism].
    Prati PL; Piazza V
    Cardiologia; 1994 Dec; 39(12 Suppl 1):353-6. PubMed ID: 7634296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
    Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
    Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
    Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
    J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.
    Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolism and antithrombotic therapy in congestive heart failure.
    Dunkman WB
    J Cardiovasc Risk; 1995 Apr; 2(2):107-17. PubMed ID: 7606647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 6():112-7. PubMed ID: 11826813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of thrombocyte aggregation after heart valve replacement].
    von Schacky C
    Z Kardiol; 1998; 87 Suppl 4():46-55. PubMed ID: 9857467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of mechanical heart valve thrombosis through a clinical audit.
    Bharat V; Das NK; Mohanty B; Jha AC; Chawla SC; Dash B; Mohanty R
    J Heart Valve Dis; 2003 May; 12(3):362-9. PubMed ID: 12803337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 4():49-56. PubMed ID: 11373944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Right-sided prosthetic cardiac valve thrombosis: value of cinefluoroscopy in the diagnosis and follow-up of thrombolytic treatment].
    Hobbach HP; Mall K; Schaeffer C; Schuster P
    Dtsch Med Wochenschr; 2009 Oct; 134(41):2059-63. PubMed ID: 19802766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.